“…Recently, because of their specially pharmaceutical and biological activities, compounds with pyrrole rings such as dihydro-2-oxypyrroles and Biginelli [5] reactions for the synthesis of 3, 4-dihydropyrimidin-2-(1H)-ones derivatives have attracted much interest in the organic researches for example these compounds have been used as anticancer [6], calcium channel blockers, α-1a-antagonists [7], human cytomegalovirus ( HCMV) protease [8], they has been used as Pl-091 [9], many of number alkaloids with biological activities have pyrrole rings [10], And these rings have been used as UCS1025A [11]. In the recent years, several protocols for the preparation of these compounds that is including bronsted or lewis acid catalysts have been reported for example Cu(OAc) 2 [12], [Btto][p-TSA] [13], bakers , yeast [14], Calcium Fluoride [15], copper(II) tetrafluoroborate [16], hydrotalcite [17], TBAB [18], hexaaquaaluminium(III) tetrafluoroborate [19], copper(II)sulfamate [20], I 2 [21], AcOH [22], [n-Bu 4 3 [24], oxalic acid [25], ZrCl 4 [26], InCl 3 [27]. Some of limitation these methodologies are low yields, toxic catalyst, long time reactions, harsh reaction conditions, expensive materials.…”